Literature DB >> 2885714

Activator proteins for lysosomal glycolipid hydrolysis.

E Conzelmann, K Sandhoff.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2885714     DOI: 10.1016/0076-6879(87)38068-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

1.  Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.

Authors:  P Leinekugel; S Michel; E Conzelmann; K Sandhoff
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

Review 2.  The anomalous kinetics of sulphatase A.

Authors:  A B Roy; T J Mantle
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

3.  Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study.

Authors:  W Schlote; K Harzer; H Christomanou; B C Paton; B Kustermann-Kuhn; B Schmid; J Seeger; U Beudt; I Schuster; U Langenbeck
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

4.  Diagnosis and prevention of lysosomal storage diseases in Russia.

Authors:  K D Krasnopolskaya; T V Mirenburg; E L Aronovich; T V Lebedeva; O N Odinokova; N A Demina; V M Kozlova; M I Kuznetsov
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.

Authors:  B Schmid; B C Paton; K Sandhoff; K Harzer
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

6.  Identification of a lysosomal protein causing lipid transfer, using a fluorescence assay designed to monitor membrane fusion between rat liver endosomes and lysosomes.

Authors:  T Kuwana; B M Mullock; J P Luzio
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

7.  Action of alpha-L-fucoside from Octopus vulgaris hepatopancreas on phospholipid vesicles containing the fucosylated ganglioside FucGM1.

Authors:  A Giuliani; P Palestini; A D'Aniello; M Masserini
Journal:  Glycoconj J       Date:  1993-12       Impact factor: 2.916

Review 8.  [Sphingolipid storage diseases of the central nervous system: bases of biochemical and clinical heterogeneity].

Authors:  K Sandhoff; L Quintern
Journal:  Naturwissenschaften       Date:  1988-03

9.  Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.

Authors:  V Bradová; F Smíd; B Ulrich-Bott; W Roggendorf; B C Paton; K Harzer
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

10.  Requirement of GM2 ganglioside activator for phospholipase D activation.

Authors:  S Nakamura; T Akisue; H Jinnai; T Hitomi; S Sarkar; N Miwa; T Okada; K Yoshida; S Kuroda; U Kikkawa; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.